Detection of tumor‐specific DNA in blood and bone marrow plasma from patients with prostate cancer
Authors:
- Felix K.‐H. ChunFCFelix K.‐H. Chun
- Imke LangeILImke Lange
- Martin G. FriedrichMFMartin G. Friedrich
- Hartwig HulandHHHartwig Huland
- Klaus PantelKPKlaus Pantel
Open Access
- 30 January 2007
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 120 (7) , 1465-1471
Abstract
Tumor tissues, blood plasma and bone marrow (BM) aspirates of 57 prostate cancer patients (PCa) without clinical signs of overt metastases were assessed for LOH (loss of heterozygosity) by a PCR‐based fluorescence microsatellite analysis, using a panel of 15 markers. Additionally, micrometastatic tumor cells in BM were monitored by an immunocytological cytokeratin assay. In total, 25 (44%), 32 (56%) and 41 (72%) of the patients had at least 1 LOH in their blood, BM and tumor samples, respectively. Among the informative cases, the frequency of LOH was highest in blood plasma for the markers D8S360 (18%) and D10S1765 (15%), and in BM plasma for THRB (24%) and D8S137 (22%). Comparison of blood plasma and BM with tumors showed discrepant results in 35% and 45% of patients, respectively. Whereas all LOHs at THRB in BM plasma were also detected in the autologous tumor tissues, LOHs at D6S474 and D11S898 in BM were not retrieved in the tumors. The comparison with established risk factors showed a correlation of borderline significance for LOH at D9S1748 in the BM aspirates (p = 0.055) and a significant correlation in the tumor samples (p = 0.004) with increasing pathologic Gleason scores. Interestingly, 22% of the PCa patients harbored tumor cells in their BM and tended (p = 0.065) to have more frequent LOH (16%) in BM plasma compared to patients without tumor cells (9%). These data demonstrate, for the first time, the presence of free tumor‐specific DNA in blood and BM of PCa patients and suggest a possible relationship to BM micrometastasis.Keywords
This publication has 39 references indexed in Scilit:
- Comparison of Genetic Alterations Detected in Circulating Microsatellite DNA in Blood Plasma Samples of Patients with Prostate Cancer and Benign Prostatic HyperplasiaAnnals of the New York Academy of Sciences, 2006
- A Pooled Analysis of Bone Marrow Micrometastasis in Breast CancerNew England Journal of Medicine, 2005
- Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?Lung Cancer, 2005
- Dissecting the metastatic cascadeNature Reviews Cancer, 2004
- Detection and Characterization of Circulating Microsatellite‐DNA in Blood of Patients with Breast CancerAnnals of the New York Academy of Sciences, 2004
- Genetic heterogeneity of single disseminated tumour cells in minimal residual cancerThe Lancet, 2002
- Molecular cytogenetics of prostate cancerMicroscopy Research and Technique, 2000
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancerGenes, Chromosomes and Cancer, 1998
- Isolation and characterization of DNA from the plasma of cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1987